OEM Luxury Pore Tightening Anti Aging Priming Pre-Toner

Name: OEM Luxury Pore Tightening Anti Aging Priming Pre-Toner
Brand: Guangzhou Zohe Wellness Technology Co. Ltd
SKU: 2312624195

Guangdong, ChinaGuangzhou Zohe Wellness Technology Co. Ltd

US$7.20

1,000-4,999 Pieces

US$6.58

5,000-9,999 Pieces

US$6.29

10,000+ Pieces

Sample price:US$10.00/piece.Request sample

Product profile

Customization

Available

Certification

GMP, FDA

Main Ingredient

collagen, plant, Deep Sea Algae Extract

Model NO.

150ml

Feature

Skin Revitalizer, Nourishing, Moisturizer, Firming, Anti-Wrinkle, Anti-Aging

Form

Lotion

Gender

Female

Use

Face, Eye

Selling Point

Deep Hydration

Selling Point2

Unlock Skin Absorption

Selling Point3

Boost Collagen Anti Aging

Selling Point5

Gentle Exfoliation

Selling Point4

Priming Toner for All Skin Types

Transport Package

Box

Specification

175*55*80mm, 435g

Trademark

OEM/ODM Acceptable

Origin

China

Company profile

Importers and ExportersSelf-brandedODM ServicesQuality Assurance

Guangzhou Zohe Wellness Technology Co. Ltd

Guangdong, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 1 Year CertifiedNearest Port: Guangzhou Port, Shenzhen PortAverage Response Time: ≤1.39h

AI-Powered supplier vetting

SummaryZohe Wellness reports technology development and consulting activities, sales of Class I medical devices, more than 10 production lines, and domestic primary markets. It offers extensive customization and ODM services, with standardized finished-product inspection instructions and quality assurance procedures. However, it has exported for only one year, has no stated management-system certifications, no overseas warehouse, showroom, agents, branches, or trade-show participation, and lacks valid manufacturing-capacity contracts with related subcontractors. Its corrective-action and complaint-handling procedures have no written records, while supplier-service assessment procedures also lack records. No new products were reported in the past year, no SDK is available, and the disclosed financial figures are zero, limiting evidence of financial strength. No customer cases or named brand OEM experience are provided.

Supplier typeThe supplier describes a business scope centered on gene diagnosis and treatment technology development and application, technical services, consulting, technology transfer, health consulting, and sales of Class I medical devices. Its primary export market is domestic, indicating a technology and medical-device-related supplier with limited demonstrated export orientation.

CertificationsThe supplier management-system certification field is explicitly recorded as NIL. This is a stated absence of certification evidence rather than merely incomplete disclosure.

Financial creditThe disclosed operating revenue, operating cost, gross profit, operating profit, gross margin, and current-ratio values are zero for the stated periods. These figures provide no positive evidence of operating financial strength and materially limit confidence in the supplier's demonstrated financial activity.

Production capacityThe supplier operates above 10 production lines, reports in-stock capacity, and states peak- and off-season lead times within 15 workdays. However, it has no valid contract covering manufacturing capacity with related subcontractors, creating a documented gap in production-capacity governance.

Customization capabilityBoth design-service and R&D-service records explicitly list customization from samples, designs, full customization, minor customization, and flexible customization. ODM service is also available, providing strong direct evidence of broad customization capability.